This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors, was published in Drug Metabolism and Disposition (DMD) Westbury, NY – Aug. 15, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways.1 Previously published studies had appeared to show a correlation…

QxMD Builds on Medscape’s Point-of-Care Tools and Services New York, NY, August 12, 2019: WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, has acquired QxMD, a Vancouver, BC-based learning technology company that delivers mobile decision point tools and personalized learning solutions for physicians and health care professionals (HCPs). The acquisition, announced today, combines QxMD’s unrivaled online clinical calculators and other digital learning tools for HCPs with the content, reference, point-of-care and…

Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio. Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing Centre (“CGTCMC”). Kadans will redevelop and extend Sycamore House into a modern, vibrant, multi-tenanted R&D facility with expected completion mid-2021. The building will provide grow-on space for overflowing demand from SBC and CGTCMC…

CAMBRIDGE, UK, 09 August 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with Clustermarket, a leading online equipment sharing and booking platform and Science Entrepreneur Club, a life sciences network, to help drive the translation of world-class life science and healthcare research into commercially successful companies. As part of the agreement, Start Codon will be co-sponsoring the Connect2Innovate Meetup on Tuesday 13th August 2019, 18:00-21:00 at The Bradfield Centre, Cambridge. Founded in April 2019, Start Codon…

Click here for the latest edition of eNews. 

This transaction increases BioIVT’s portfolio of disease-state plasma, sera and controls, and enhances its ability to support the in vitro diagnostic market Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range. “With the addition of Keystone Biologicals, BioIVT broadens its product…

This Transaction Increases BioIVT’s Portfolio of Disease-State Plasma, Sera and Controls, and Enhances its Ability to Support the In Vitro Diagnostic Market   Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.“With the addition of Keystone Biologicals, BioIVT broadens its…

Cambridge, UK, 6th August 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, welcomed Mrs Kemi Badenoch, MP for Saffron Walden, to its offices at Chesterford Research Park.Arecor’s Chief Executive Officer, Dr Sarah Howell and Chief Financial Officer, Susan Lowther, met with Mrs Badenoch MP, to discuss the current climate for small companies in the UK healthcare industry.They covered a wide range of topics from the…

Lonza Signs 15-year Lease of the 42,000 sq ft Gonville Building at Chesterford Research Park  Cambridge, UK, 06 August 2019: Chesterford Research Park is delighted to welcome Lonza to Chesterford Research Park.The Swiss multinational CDMO, which provides contract development and manufacturing services to the pharmaceutical and biotech industries, has signed a 15-year lease of the 42,000 sq ft Gonville building, an impressive two-winged building, linked by a central reception block. Situated at the heart of the Park and within easy reach of The Nucleus central facilities building, the…

BETHESDA, MD – August 1, 2019 – Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise in the biospecimen solutions space. With the acquisitions, Precision now offers an unmatched level of scientific understanding, high-quality specimen solutions, and global scale.The addition of ProMedDx and GLAS establishes an unrivalled biospecimen solutions platform within Precision, which operates one of the largest biorepositories in the world. ProMedDx is known throughout…